Abiomed stock rockets after J&J buyout deal worth $16.6 billion
Shares in Abiomed Inc. ABMD, -2.32% rocketed 48.8% to a 14-month high in premarket trading Tuesday after the provider of medical technology that supports circulation and oxygenation agreed to be bought by Johnson & Johnson JNJ, -0.51% in a deal worth DKK 16.6 billion. Under the deal, J&J will pay $380 in upfront cash for … Read more